{"id":51,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=51"},"modified":"2026-06-14T22:22:13","modified_gmt":"2026-06-14T20:22:13","slug":"tirzepatid-mounjaro","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/sv\/shop\/tirzepatide-mounjaro\/","title":{"rendered":"Tirzepatid \/ Mounjaro"},"content":{"rendered":"

Tirzepatide - Peptid med dubbel agonist f\u00f6r metabolism och viktkontroll<\/strong><\/p>\n

Sammans\u00e4ttning:<\/strong>\u00a0Tirzepatide (frystorkat peptidpulver)
Kategori:<\/strong> Peptid
Form:<\/strong> Flaska med frystorkat pulver
Administration:<\/strong> Subkutan injektion efter rekonstitution med bakteriostatiskt vatten<\/p>\n

\n

Vad \u00e4r Tirzepatide?<\/h3>\n

Tirzepatid<\/strong> \u00e4r en dubbel inkretinreceptoragonist<\/strong> som samtidigt aktiverar GLP-1 (glukagonliknande peptid-1)<\/strong>och GIP (glukosberoende insulinotropisk polypeptid)<\/strong> receptorer.
Denna dubbla mekanism g\u00f6r det till en N\u00e4sta generations peptid<\/strong> i forskning om metabolism och viktreglering<\/strong>, som kombinerar glukoss\u00e4nkande effekter av GLP-1-agonister<\/strong> med metaboliska f\u00f6rdelar med GIP-stimulering.<\/strong><\/p>\n

Genom att aktivera b\u00e5da signalv\u00e4garna har Tirzepatide visat en stark potential i prekliniska och kliniska studier<\/strong> f\u00f6r att f\u00f6rb\u00e4ttra Insulink\u00e4nslighet, minskning av kroppsfett,<\/strong> och optimering av Energimetabolism.<\/strong><\/p>\n

\u27a1\ufe0f Idealisk f\u00f6r metabolisk h\u00e4lsa, insulinreglering,<\/strong> och forskning om mekanismer f\u00f6r fetma.<\/strong><\/p>\n

\n

Viktiga forskningsresultat<\/h3>\n

Dubbel receptoraktivering:<\/strong> Stimulerar b\u00e5de GLP-1<\/strong> och GIP-receptorer<\/strong> f\u00f6r synergistisk metabolisk f\u00f6rb\u00e4ttring.<\/p>\n

Glukosreglering:<\/strong> Fr\u00e4mjar insulinsekretion<\/strong> och f\u00f6rb\u00e4ttrar glukoshomeostas.<\/strong><\/p>\n

Fettminskning:<\/strong> Leder till minskning av kroppsfett<\/strong> och samtidigt bibeh\u00e5lla mager kroppsmassa.<\/strong><\/p>\n

Aptitkontroll:<\/strong> Reglerar centrala mekanismer som styr hunger och m\u00e4ttnad.<\/strong><\/p>\n

Energimetabolism:<\/strong> F\u00f6rb\u00e4ttrar mitokondriell effektivitet<\/strong> och fettoxidation.<\/strong><\/p>\n

\n

Dosering och anv\u00e4ndning<\/h3>\n

\u00c5terst\u00e4ll med bakteriostatiskt vatten<\/strong> f\u00f6re anv\u00e4ndning.<\/p>\n

Typiskt forskningsomr\u00e5de: 0,25-1,0 mg per applicering<\/strong>, subkutant, en eller tv\u00e5 g\u00e5nger i veckan<\/strong> beroende p\u00e5 studiens utformning.<\/p>\n

F\u00f6rvara den rekonstituerade l\u00f6sningen kyld<\/strong> och anv\u00e4ndning inom 30 dagar.<\/strong><\/p>\n

\n

Instruktioner f\u00f6r f\u00f6rvaring<\/h3>\n
    \n
  • \n

    Butik p\u00e5 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Skydda fr\u00e5n ljus och fukt<\/strong><\/p>\n<\/li>\n

  • \n

    F\u00e5r inte frysas<\/strong><\/p>\n<\/li>\n

  • \n

    Undvik temperaturfluktuationer<\/p>\n<\/li>\n<\/ul>\n

    \n

    Varf\u00f6r v\u00e4lja Tirzepatide?<\/h3>\n

    Tirzepatid<\/strong> \u00e4r en av de mest avancerade inkretinbaserade peptider<\/strong> f\u00f6r n\u00e4rvarande under forskning.
    Genom sin aktivering av dubbla receptorer<\/strong>, erbjuder den en unik profil<\/strong> f\u00f6r optimerad metabolisk kontroll och viktkontroll.<\/strong>
    Dess effekter p\u00e5 glukosmetabolism, fettoxidation,<\/strong> och energibalans<\/strong> g\u00f6ra det till en v\u00e4rdefullt verktyg<\/strong> i endokrin och metabolisk forskning.<\/strong><\/p>\n

    Best\u00e4ll Tirzepatide<\/strong>\u00a0och utforska dess potential i avancerad forskning om \u00e4mnesoms\u00e4ttning och fetma.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Tirzepatide \u00a0\u2013 Dual-Agonist Peptide for Metabolic & Weight Management Composition:\u00a0Tirzepatide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Tirzepatide? Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation. By activating both signaling pathways, Tirzepatide has shown strong potential in preclinical and clinical studies for improving insulin sensitivity, reducing body fat, and optimizing energy metabolism. \u27a1\ufe0f Ideal for metabolic health, insulin regulation, and obesity mechanism research. Key Research Findings Dual Receptor Activation: Stimulates both GLP-1 and GIP receptors for synergistic metabolic enhancement. Glucose Regulation: Promotes insulin secretion and improves glucose homeostasis. Fat Reduction: Leads to body fat reduction while maintaining lean body mass. Appetite Control: Regulates central mechanisms controlling hunger and satiety. Energy Metabolism: Enhances mitochondrial efficiency and fat oxidation. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously, once or twice weekly depending on study design. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Tirzepatide? Tirzepatide is one of the most advanced incretin-based peptides currently under research.Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management.Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research. Order Tirzepatide\u00a0and explore its potential in advanced metabolic and obesity research.<\/p>","protected":false},"featured_media":126830,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":["post-51","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-glp-1andmultiagonist","product_cat-metabolismandweightmanagement","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","purchasable","product-type-variable"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t